Cutia Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Cutia Therapeutics has a total shareholder equity of CN¥1.2B and total debt of CN¥210.3M, which brings its debt-to-equity ratio to 17.7%. Its total assets and total liabilities are CN¥1.5B and CN¥319.4M respectively.
Key information
17.7%
Debt to equity ratio
CN¥210.33m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.04b |
| Equity | CN¥1.19b |
| Total liabilities | CN¥319.44m |
| Total assets | CN¥1.51b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2487's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥237.8M).
Long Term Liabilities: 2487's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥81.7M).
Debt to Equity History and Analysis
Debt Level: 2487 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2487's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2487 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 2487 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.